Longwood Special Situations
Venture capitalBoston
Fund manager profile
Longwood Special Situations is a venture fund manager based in Boston. SEC filings show 1 venture fund on record, most recently Longwood Special Situations Fund, L.P. ($200M offering) filed December 2024.
Source: SEC EDGAR Form D filings. Firm website data not yet available.
What they invest in
from 1 of 1 portfolio companiesBiotech ×1Healthtech ×1Medical Devices ×1
HQs:United States×1
Investments · 1 tracked
founders shown can be your intro pathTScan Therapeutics is a clinical-stage biotechnology company developing T cell receptor-engineered T cell (TCR-T) therapies for cancer patients.
BiotechHealthtechMedical DevicesBoston, US
David Southwell(Executive Officer, Director)Robert Crane(Executive Officer)
BoardLea Hachigian(Director)Steve Kraus(Director)inCampbell Murray(Director)Hannes Smarason(Director)in
Board seatChristoph Westphal· per SEC Form D · $100M raise · filed Jan 2021
Co-investorsAstellas Venture Management LLCBessemer Venture PartnersLongwood FundRA Capital6 Dimensions CapitalPitango
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Portfolio news
latest coverage across their companiesFrequently asked questions
- Where is Longwood Special Situations located?
- Longwood Special Situations is headquartered in Boston, US.